0001699350-26-000011
SEC filingSHOULDER INNOVATIONS, INC. reported a net loss of $40.4 million for fiscal year 2025, driven by an operating loss of $26.3 million despite generating $47.3 million in net revenue. The company's gross profit was $36.2 million, representing a gross margin of 76.5%, but this was offset by high selling, general, and administrative expenses of $54.8 million and research and development expenses of $7.7 million. The comprehensive loss also totaled $40.4 million, including an $80,000 unrealized loss on marketable securities. The company ended the year with $169.9 million in total assets, including $157.2 million in current assets, and maintained a strong liquidity position with $26.9 million in cash and cash equivalents and $97.4 million in marketable securities. Total liabilities were $29.2 million, resulting in stockholders' equity of $140.8 million. Cash flow from operations was negative $28.6 million, while financing activities provided $145.0 million primarily from IPO proceeds and convertible note issuances.
SHOULDER INNOVATIONS, INC. reported significant losses for fiscal year 2025, with a net loss of $40.4 million on net revenue of $47.3 million. The company generated gross profit of $36.2 million from its operations, representing a gross margin of 76.5%. However, operating expenses totaled $62.5 million, consisting of $54.8 million in selling, general, and administrative expenses and $7.7 million in research and development expenses, resulting in an operating loss of $26.3 million. Other expenses contributed to the total loss, including $2.2 million from changes in fair value of convertible notes and $11.7 million from changes in fair value of Series E purchase option. The comprehensive loss matched the net loss at $40.4 million, with an additional $80,000 unrealized loss on marketable securities.
The company reported net revenue of $47.3 million for fiscal year 2025. Cost of goods sold was $11.1 million, resulting in gross profit of $36.2 million. No segment breakdown or geographic revenue mix was provided in the available data. The revenue generation appears to be from the company's core operations, though specific product lines or service categories are not detailed in the provided financial statements. The absence of segment reporting suggests the company operates as a single reporting unit or that segment data was not required to be disclosed in this filing.
The company maintained a strong gross margin of 76.5% for fiscal year 2025, calculated from $36.2 million gross profit on $47.3 million revenue. However, profitability was significantly impacted by high operating expenses. Selling, general, and administrative expenses of $54.8 million represented 115.9% of revenue, while research and development expenses of $7.7 million represented 16.3% of revenue. The operating margin was negative 55.6%, reflecting the substantial operating loss. The net loss margin was negative 85.4%, indicating significant challenges in achieving profitability despite healthy gross margins.
Cash flow from operating activities was negative $28.6 million, primarily driven by the net loss of $40.4 million, partially offset by non-cash adjustments including $3.2 million in depreciation and amortization and $12.0 million in changes in fair value of warrant liabilities and Series E purchase option. Investing activities used $95.6 million in cash, mainly for purchases of marketable securities ($119.5 million) and fixed assets ($7.4 million). Financing activities provided $145.0 million, with significant contributions from IPO proceeds ($64.2 million), convertible note issuances ($39.9 million), and Series E convertible preferred stock ($39.5 million). The balance sheet shows total assets of $169.9 million, including current assets of $157.2 million with substantial marketable securities ($97.4 million) and cash ($26.9 million). Total liabilities were $29.2 million, resulting in stockholders' equity of $140.8 million.
No specific management guidance, strategic priorities, or forward-looking statements were provided in the available financial data. The filing contains standard financial statements without accompanying management discussion and analysis that would typically include outlook information. The company's significant cash position from recent financing activities ($145.0 million from financing) suggests resources available for future operations, but no explicit guidance on expected performance, growth initiatives, or risk factors beyond the presented financial results is included in the provided data.